Cancer Policy Trump administration announces “major crackdown” on healthcare fraud February 27, 2026Vol.52 No.08By Claire Marie Porter
Cancer Policy FDA issues draft guidance on accelerating development of individualized therapies for ultra-rare diseases February 27, 2026Vol.52 No.08
In Brief Lou Weiner to step down as director of Georgetown’s Lombardi CCC after 18 years February 27, 2026Vol.52 No.08
In Brief David Weinberg named VP, associate director for cancer screening & prevention at Fox Chase February 27, 2026Vol.52 No.08
In Brief Frank Smith named president of XenoSTART preclinical business unit February 27, 2026Vol.52 No.08
Clinical Roundup NHS-Galleri MCD trial fails to meet primary endpoint of stage shift February 27, 2026Vol.52 No.08By Sara Willa Ernst
Clinical Roundup Phase I/II PYNNACLE trial evaluating rezatapopt shows proof of concept for p53 reactivation February 27, 2026Vol.52 No.08
